Manuel Battegay
机构: University of Basel, Switzerland
每年引用次数
引用次数
引用: 41,734
H-指数: 101
I10-指数 : 476
出版物: 1,026
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation
Salathé Marcel , Althaus L Christian , Neher Richard , Stringhini Silvia
Swiss medical weekly 150 w202205 -w202205
600
2020
Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO)
Letang Emilio , Kalinjuma Aneth Vedastus , Glass R Tracy , Gamell Anna
SWISS MEDICAL WEEKLY 147
2017
Low Rates of Active Hepatitis B and C Infections Among Adults and Children Living With HIV and Taking Antiretroviral Therapy: A Multicenter Screening Study in Lesotho
Amstutz Alain , L Nsakala Bienvenu , Cheleboi Molisana , I Lejone Thabo
Journal of medical virology
Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008
Karoline Aebi-Popp , Olav Lapaire , Tracy R. Glass , Louise Vilén
Journal of Perinatal Medicine 38 ( 4) 353 -358
28
2010
Swiss HIV cohort study (SHCS): outcome and perspectives.
M. P. Glauser , P. Francioli , M. Battegay , M. Rickenbach
Suisse-Sida-Recherche 4 -33
2001
Characterisation of hepatitis C virus evolution in HIV/HCV coinfected individuals using deep sequencing technology: Relevance for new antiviral drugs and disease outcome
S. Gaudieri , M. Battegay , H. Günthard , S. Mallal
Tschochner, M. <http://researchrepository.murdoch.edu.au/view/author/Tschochner, Monika.html>, Rohrbach, J., Cooper, D. <http://researchrepository.murdoch.edu.au/view/author/Cooper, Donald.html>, Merani, S., Chopra, A. <http://researchrepository.murdoch.edu.au/view/author/Chopra, Abha.html>, Witteck, A., Battegay, M., Furrer, H., Günthard, H., Mallal, S. <http://researchrepository.murdoch.edu.au/view/author/Mallal, Simon.html>, Rauch, A. <http://researchrepository.murdoch.edu.au/view/author/Rauch, Andri.html> and Gaudieri, S. <http://researchrepository.murdoch.edu.au/view/author/Gaudieri, Silvana.html> (2010) Characterisation of hepatitis C virus evolution in HIV/HCV coinfected individuals using deep sequencing technology: Relevance for new antiviral drugs and disease outcome. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia
2010
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group : Response to combination antiretroviral therapy: variation by age
J. Warszawski , M. Battegay , C. Gabiano , A. d Arminio Monforte
Current Science
50
2008
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
M. Battegay , R. M. Zinkernagel , M.-A. Bründler , H. Hengartner
Journal of Immunology 151 ( 10) 5408 -5415
120
1993
CALCIUMCARBONAT FUR DIE BEHANDLUNG DER HYPERPHOSPHATAMIE BEI CHRONISCHEN HAMODIALYSEPATIENTEN
A. Lyrer , D. Kiss , M. Battegay , Carl Richard Meier
Schweizerische Medizinische Wochenschrift 120 ( 9) 295 -298
1
1990
Prévention primaire et dépistage chez l'adulte : quelles sont les priorités en 2002 ? : Médecine de premier recours
J. Cornuz , M. Battegay , P. Hengstler , J.-P. Gervasoni
Medecine Et Hygiene 60 ( 2411) 2008 -2016
1
2002
HIV-INFECTION UND LUES : FALLBESCHREIBUNG UND LITERATURUBERSICHT
M. Battegay , A. Steiner , R. Luthy , P. Greminger
Schweizerische Medizinische Wochenschrift 121 ( 3)
1991
Impact des nouvelles associations thérapeutiques sur l'incidence du Sida dans l'étude suisse de cohorte VIH
M. Battegay , P. Sudre , M. Rickenbach , B. Ledergerber
Medecine Et Hygiene 56 ( 2215) 1382 -1386
1998
KLINISCH SIGNIFIKANTE MEDIKAMENTOSE INTERAKTIONEN BEI HIV-INFIZIERTEN PATIENTEN
M. Weisser , M. Battegay
Therapeutische Umschau 55 ( 5) 310 -322
1998
Identification of HCV minority species in HIV/HCV coinfected individuals using deep sequencing technology: relevance for new anti-HCV drugs and host immune responses to HCV.
S. Gaudieri , M. Battegay , H. Günthard , H. Furrer
Gaudieri, S. <https://researchrepository.murdoch.edu.au/view/author/Gaudieri, Silvana.html>, Tschochner, M. <https://researchrepository.murdoch.edu.au/view/author/Tschochner, Monika.html>, Cooper, D. <https://researchrepository.murdoch.edu.au/view/author/Cooper, Donald.html>, Chopra, A. <https://researchrepository.murdoch.edu.au/view/author/Chopra, Abha.html>, Merani, S., Witteck, A., Battegay, M., Günthard, H., Furrer, H., Rohrbach, J. and Rauch, A. (2010) Identification of HCV minority species in HIV/HCV coinfected individuals using deep sequencing technology: relevance for new anti-HCV drugs and host immune responses to HCV. In: The 17th International Meeting on Hepatitis C Virus and Related Diseases., 10 - 14 September 2010, Yokohama, Japan.
2010
The significance of pre-existing minority Y181C mutations on virological failure of NNRTI-based, first-line antiretroviral therapy
M. Battegay , S. Yerly , E. Bernasconi , T. Klimkait
International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies 16
1
2011
Prescribing issues in the Swiss HIV infected ageing population
M. Battegay , F. Livio , C. Marzolini , M. Cavassini
Drug Safety 41 ( 11) 1252 -1253
2018
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infection
A. Haas , K. Zimmermann , F. Graw , E. Slack
Gut 60 ( 11) 1506 -1519
54
2011
Is there a relation between risk groups or initial CD4 T cell counts and prevalence of seborrheic dermatitis in HIV-infected patients?
N.A. Schaub , J. Drewe , L. Sponagel , L. Gilli
Dermatology 198 ( 2) 126 -129
15
1999
Oral Manifestation of Disseminated Mycobacterium kansasii Infection in a Patient with AIDS
R Nüesch , M Battegay , W Zimmerli , M Thumshirn
Dermatology 192 ( 2) 183 -184
5
1996
Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care.
H. H. Hirsch , H. Drechsler , A. Holbro , F. Hamy
European Journal of Clinical Microbiology & Infectious Diseases 24 ( 11) 733 -738
15
2005